Número 4 de la revista AIDS del 2012
Publicada AIDS, volumen 26, número 4, febrero 20 del 2012. Los usuarios de la red sld.cu tiene acceso al texto completo de esta publicación a través de Hinari. Algunos de sus titulares son:
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients
HIV infection and risk of overdose: a systematic review and meta-analysis
Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn
Altered dendritic cell–natural killer interaction in Kenyan sex workers resistant to HIV-1 infection
Periodic presumptive treatment of curable sexually transmitted infections among sex workers: a systematic review
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents
Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy
A randomized trial of a behavioral intervention for black MSM: the DiSH study
Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era
Hormonal contraception and the risk of HIV acquisition among women in South Africa
High HIV incidence among MSM prescribed postexposure prophylaxis, 2000–2009: indications for ongoing sexual risk behaviour
Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships
Treatment as prevention: some additional thoughts
Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment
Rare LEDGF/p75 genetic variants in white long-term nonprogressor HIV+ individuals
